Sepsis and Pediatric Acute Respiratory Distress Syndrome

Nadir Yehya; Neal J. Thomas

doi:10.1055/s-0038-1676133

Journal of Pediatric Intensive Care, Table of Contents

J Pediatr Intensive Care 2019; 08(01): 032-041
DOI: 10.1055/s-0038-1676133

Review Article

Georg Thieme Verlag KG Stuttgart · New York

Sepsis and Pediatric Acute Respiratory Distress Syndrome

Nadir Yehya

¹Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania, United States

,

Neal J. Thomas

²Division of Pediatric Critical Care Medicine, Department of Pediatrics and Public Health Science, Penn State Hershey Children's Hospital, Hershey, Pennsylvania, United States

› Author Affiliations

Abstract

The epidemiology of the acute respiratory distress syndrome (ARDS) in pediatric sepsis is poorly defined. With significant data extrapolated from adult studies in sepsis and ARDS, sometimes with uncertain applicability, better pediatric-specific guidelines and dedicated investigations are warranted. The recent publication of a consensus definition for pediatric ARDS (PARDS) is the first step in addressing this knowledge gap. The aim of this review is to frame our current understanding of PARDS as it relates to pediatric sepsis, encompassing epidemiology, pathophysiology, and management. We argue that addressing the role of PARDS in pediatric sepsis requires significant attention to details with respect to how PARDS and sepsis are defined to accurately describe their epidemiology, natural history, and outcomes. Finally, we highlight certain aspects of PARDS management as they relate to the septic child and offer suggestion for future directions in this field.

Keywords

sepsis - septic shock - children - pediatric - acute respiratory distress syndrome - pediatric acute respiratory distress syndrome

Full Text

References

References
1 Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2 (7511): 319-323
2 Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138 (03) 720-723
3 Bernard GR, Artigas A, Brigham KL. , et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149 (3, Pt 1): 818-824
4 Taylor RW, Zimmerman JL, Dellinger RP. , et al; Inhaled Nitric Oxide in ARDS Study Group. Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004; 291 (13) 1603-1609
5 Zeiher BG, Artigas A, Vincent JL. , et al; STRIVE Study Group. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 2004; 32 (08) 1695-1702
6 Steinberg KP, Hudson LD, Goodman RB. , et al; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354 (16) 1671-1684
7 Matthay MA, Brower RG, Carson S. , et al; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network. Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 2011; 184 (05) 561-568
8 Gao Smith F, Perkins GD, Gates S. , et al; BALTI-2 study investigators. Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012; 379 (9812): 229-235
9 McAuley DF, Laffey JG, O'Kane CM. , et al; HARP-2 Investigators; Irish Critical Care Trials Group. Simvastatin in the acute respiratory distress syndrome. N Engl J Med 2014; 371 (18) 1695-1703
10 Truwit JD, Bernard GR, Steingrub J, et al; National Heart, Lung, and Blood Institute ARDS Clinical Trial Network. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med 2014; 370 (23) 2191-2200
11 Willson DF, Truwit JD, Conaway MR, Traul CS, Egan EE. The Adult Calfactant in Acute Respiratory Distress Syndrome Trial. Chest 2015; 148 (02) 356-364
12 The ARDS Network. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2000; 283 (15) 1995-2002
13 Anzueto A, Baughman RP, Guntupalli KK. , et al; Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996; 334 (22) 1417-1421
14 Spragg RG, Lewis JF, Walmrath HD. , et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004; 351 (09) 884-892
15 Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. ; Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342 (18) 1301-1308
16 Wiedemann HP, Wheeler AP, Bernard GR. , et al; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354 (24) 2564-2575
17 Ranieri VM, Rubenfeld GD, Thompson BT. , et al; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307 (23) 2526-2533
18 Papazian L, Forel JM, Gacouin A. , et al; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363 (12) 1107-1116
19 Guérin C, Reignier J, Richard JC. , et al; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368 (23) 2159-2168
20 Trachsel D, McCrindle BW, Nakagawa S, Bohn D. Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure. Am J Respir Crit Care Med 2005; 172 (02) 206-211
21 Flori HR, Glidden DV, Rutherford GW, Matthay MA. Pediatric acute lung injury: prospective evaluation of risk factors associated with mortality. Am J Respir Crit Care Med 2005; 171 (09) 995-1001
22 Erickson S, Schibler A, Numa A. , et al; Paediatric Study Group; Australian and New Zealand Intensive Care Society. Acute lung injury in pediatric intensive care in Australia and New Zealand: a prospective, multicenter, observational study. Pediatr Crit Care Med 2007; 8 (04) 317-323
23 López-Fernández Y, Azagra AM, de la Oliva P. , et al; Pediatric Acute Lung Injury Epidemiology and Natural History (PED-ALIEN) Network. Pediatric Acute Lung Injury Epidemiology and Natural History study: Incidence and outcome of the acute respiratory distress syndrome in children. Crit Care Med 2012; 40 (12) 3238-3245
24 Yehya N, Keim G, Thomas NJ. Subtypes of pediatric acute respiratory distress syndrome have different predictors of mortality. Intensive Care Med 2018; 44 (08) 1230-1239
25 Himebauch AS, Yehya N, Wang Y. , et al. Early Right Ventricular Systolic Dysfunction and Pulmonary Hypertension Are Associated With Worse Outcomes in Pediatric Acute Respiratory Distress Syndrome. Crit Care Med 2018; 46 (11) e1055-e1062
26 Thomas NJ, Shaffer ML, Willson DF, Shih MC, Curley MA. Defining acute lung disease in children with the oxygenation saturation index. Pediatr Crit Care Med 2010; 11 (01) 12-17
27 Khemani RG, Thomas NJ, Venkatachalam V. , et al; Pediatric Acute Lung Injury and Sepsis Network Investigators (PALISI). Comparison of SpO₂ to PaO₂ based markers of lung disease severity for children with acute lung injury. Crit Care Med 2012; 40 (04) 1309-1316
28 Wong JJ, Loh TF, Testoni D, Yeo JG, Mok YH, Lee JH. Epidemiology of pediatric acute respiratory distress syndrome in singapore: risk factors and predictive respiratory indices for mortality. Front Pediatr 2014; 2: 78
29 Khemani RG, Rubin S, Belani S. , et al. Pulse oximetry vs. PaO₂ metrics in mechanically ventilated children: Berlin definition of ARDS and mortality risk. Intensive Care Med 2015; 41 (01) 94-102
30 Spicer AC, Calfee CS, Zinter MS. , et al. A simple and robust bedside model for mortality risk in pediatric patients with acute respiratory distress syndrome. Pediatr Crit Care Med 2016; 17 (10) 907-916
31 Parvathaneni K, Belani S, Leung D, Newth CJ, Khemani RG. Evaluating the performance of the Pediatric Acute Lung Injury Consensus Conference definition of acute respiratory distress syndrome. Pediatr Crit Care Med 2017; 18 (01) 17-25
32 Dowell JC, Parvathaneni K, Thomas NJ, Khemani RG, Yehya N. Epidemiology of cause of death in pediatric acute respiratory distress syndrome. Crit Care Med 2018; 46 (11) 1811-1819
33 Thomas NJ, Jouvet P, Willson D. Acute lung injury in children--kids really aren't just “little adults”. Pediatr Crit Care Med 2013; 14 (04) 429-432
34 Pediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distress syndrome: consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med 2015; 16 (05) 428-439
35 Yehya N, Servaes S, Thomas NJ. Characterizing degree of lung injury in pediatric acute respiratory distress syndrome. Crit Care Med 2015; 43 (05) 937-946
36 Weiss SL, Fitzgerald JC, Maffei FA. , et al; SPROUT Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators Network. Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence study. Crit Care 2015; 19: 325
37 Balamuth F, Weiss SL, Neuman MI. , et al. Pediatric severe sepsis in U.S. children's hospitals. Pediatr Crit Care Med 2014; 15 (09) 798-805
38 Nadel S, Goldstein B, Williams MD. , et al; REsearching severe Sepsis and Organ dysfunction in children: a gLobal perspective (RESOLVE) study group. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet 2007; 369 (9564): 836-843
39 Goldstein B, Giroir B, Randolph A. ; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6 (01) 2-8
40 Weiss SL, Fitzgerald JC, Pappachan J. , et al; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med 2015; 191 (10) 1147-1157
41 Leligdowicz A, Dodek PM, Norena M, Wong H, Kumar A, Kumar A. ; Co-operative Antimicrobial Therapy of Septic Shock Database Research Group. Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med 2014; 189 (10) 1204-1213
42 Zimmerman JJ, Akhtar SR, Caldwell E, Rubenfeld GD. Incidence and outcomes of pediatric acute lung injury. Pediatrics 2009; 124 (01) 87-95
43 Zinter MS, Spicer A, Orwoll BO. , et al. Plasma angiopoietin-2 outperforms other markers of endothelial injury in prognosticating pediatric ARDS mortality. Am J Physiol Lung Cell Mol Physiol 2016; 310 (03) L224-L231
44 Valentine SL, Sapru A, Higgerson RA. , et al; Pediatric Acute Lung Injury and Sepsis Investigator's (PALISI) Network; Acute Respiratory Distress Syndrome Clinical Research Network (ARDSNet). Fluid balance in critically ill children with acute lung injury. Crit Care Med 2012; 40 (10) 2883-2889
45 De Luca D, Piastra M, Chidini G. , et al; Respiratory Section of the European Society for Pediatric Neonatal Intensive Care (ESPNIC). The use of the Berlin definition for acute respiratory distress syndrome during infancy and early childhood: multicenter evaluation and expert consensus. Intensive Care Med 2013; 39 (12) 2083-2091
46 Khemani RG, Conti D, Alonzo TA, Bart III RD, Newth CJ. Effect of tidal volume in children with acute hypoxemic respiratory failure. Intensive Care Med 2009; 35 (08) 1428-1437
47 Willson DF, Thomas NJ, Tamburro R. , et al; Pediatric Acute Lung and Sepsis Investigators Network. The relationship of fluid administration to outcome in the pediatric calfactant in acute respiratory distress syndrome trial. Pediatr Crit Care Med 2013; 14 (07) 666-672
48 Flori HR, Church G, Liu KD, Gildengorin G, Matthay MA. Positive fluid balance is associated with higher mortality and prolonged mechanical ventilation in pediatric patients with acute lung injury. Crit Care Res Pract 2011; 2011: 854142
49 Calfee CS, Janz DR, Bernard GR. , et al. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest 2015; 147 (06) 1539-1548
50 Thille AW, Esteban A, Fernández-Segoviano P. , et al. Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. Am J Respir Crit Care Med 2013; 187 (07) 761-767
51 Müller-Redetzky HC, Will D, Hellwig K. , et al. Mechanical ventilation drives pneumococcal pneumonia into lung injury and sepsis in mice: protection by adrenomedullin. Crit Care 2014; 18 (02) R73
52 Fattahi F, Grailer JJ, Jajou L, Zetoune FS, Andjelkovic AV, Ward PA. Organ distribution of histones after intravenous infusion of FITC histones or after sepsis. Immunol Res 2015; 61 (03) 177-186
53 Fuchs TA, Abed U, Goosmann C. , et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007; 176 (02) 231-241
54 Clark SR, Ma AC, Tavener SA. , et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007; 13 (04) 463-469
55 Brinkmann V, Zychlinsky A. Neutrophil extracellular traps: is immunity the second function of chromatin?. J Cell Biol 2012; 198 (05) 773-783
56 Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood 2014; 123 (18) 2768-2776
57 Brinkmann V, Reichard U, Goosmann C. , et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303 (5663): 1532-1535
58 Massberg S, Grahl L, von Bruehl ML. , et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med 2010; 16 (08) 887-896
59 Xu J, Zhang X, Pelayo R. , et al. Extracellular histones are major mediators of death in sepsis. Nat Med 2009; 15 (11) 1318-1321
60 Abrams ST, Zhang N, Manson J. , et al. Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med 2013; 187 (02) 160-169
61 Bosmann M, Grailer JJ, Ruemmler R. , et al. Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury. FASEB J 2013; 27 (12) 5010-5021
62 Ekaney ML, Otto GP, Sossdorf M. , et al. Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation. Crit Care 2014; 18 (05) 543
63 Grailer JJ, Ward PA. Lung inflammation and damage induced by extracellular histones. Inflamm Cell Signal 2014; 1 (04) 1
64 Xiang M, Fan J. Pattern recognition receptor-dependent mechanisms of acute lung injury. Mol Med 2010; 16 (1,2): 69-82
65 Achouiti A, van der Meer AJ, Florquin S. , et al. High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia. Crit Care 2013; 17 (06) R296
66 Chouteau JM, Obiako B, Gorodnya OM. , et al. Mitochondrial DNA integrity may be a determinant of endothelial barrier properties in oxidant-challenged rat lungs. Am J Physiol Lung Cell Mol Physiol 2011; 301 (06) L892-L898
67 Lee YL, King MB, Gonzalez RP. , et al. Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns: a potential effector of transfusion-related acute lung injury. J Surg Res 2014; 191 (02) 286-289
68 Nakahira K, Kyung SY, Rogers AJ. , et al. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med 2013; 10 (12) e1001577 , discussion e1001577
69 Simmons JD, Lee YL, Mulekar S. , et al. Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg 2013; 258 (04) 591-596 , discussion 596–598
70 Krychtiuk KA, Ruhittel S, Hohensinner PJ. , et al. Mitochondrial DNA and toll-like receptor-9 are associated with mortality in critically ill patients. Crit Care Med 2015; 43 (12) 2633-2641
71 Maitland K, Kiguli S, Opoka RO. , et al; FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364 (26) 2483-2495
72 Piastra M, De Luca D, Pietrini D. , et al. Noninvasive pressure-support ventilation in immunocompromised children with ARDS: a feasibility study. Intensive Care Med 2009; 35 (08) 1420-1427
73 Piastra M, De Luca D, Marzano L. , et al. The number of failing organs predicts non-invasive ventilation failure in children with ALI/ARDS. Intensive Care Med 2011; 37 (09) 1510-1516
74 Mayordomo-Colunga J, Pons M, López Y. , et al. Predicting non-invasive ventilation failure in children from the SpO₂/FiO₂ (SF) ratio. Intensive Care Med 2013; 39 (06) 1095-1103
75 Bernet V, Hug MI, Frey B. Predictive factors for the success of noninvasive mask ventilation in infants and children with acute respiratory failure. Pediatr Crit Care Med 2005; 6 (06) 660-664
76 Pancera CF, Hayashi M, Fregnani JH, Negri EM, Deheinzelin D, de Camargo B. Noninvasive ventilation in immunocompromised pediatric patients: eight years of experience in a pediatric oncology intensive care unit. J Pediatr Hematol Oncol 2008; 30 (07) 533-538
77 Dohna-Schwake C, Stehling F, Tschiedel E, Wallot M, Mellies U. Non-invasive ventilation on a pediatric intensive care unit: feasibility, efficacy, and predictors of success. Pediatr Pulmonol 2011; 46 (11) 1114-1120
78 Yañez LJ, Yunge M, Emilfork M. , et al. A prospective, randomized, controlled trial of noninvasive ventilation in pediatric acute respiratory failure. Pediatr Crit Care Med 2008; 9 (05) 484-489
79 Patel BK, Wolfe KS, Pohlman AS, Hall JB, Kress JP. Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 2016; 315 (22) 2435-2441
80 Hutchings FA, Hilliard TN, Davis PJ. Heated humidified high-flow nasal cannula therapy in children. Arch Dis Child 2015; 100 (06) 571-575
81 Essouri S, Carroll C. ; Pediatric Acute Lung Injury Consensus Conference Group. Noninvasive support and ventilation for pediatric acute respiratory distress syndrome: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med 2015; 16 (05) (Suppl. 01) S102-S110
82 Messika J, Ben Ahmed K, Gaudry S. , et al. Use of high-flow nasal cannula oxygen therapy in subjects with ards: a 1-year observational study. Respir Care 2015; 60 (02) 162-169
83 Arnold JH, Hanson JH, Toro-Figuero LO, Gutiérrez J, Berens RJ, Anglin DL. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med 1994; 22 (10) 1530-1539
84 Curley MA, Hibberd PL, Fineman LD. , et al. Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trial. JAMA 2005; 294 (02) 229-237
85 Willson DF, Thomas NJ, Markovitz BP. , et al; Pediatric Acute Lung Injury and Sepsis Investigators. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA 2005; 293 (04) 470-476
86 Willson DF, Thomas NJ, Tamburro R. , et al; Pediatric Acute Lung and Sepsis Investigators Network. Pediatric calfactant in acute respiratory distress syndrome trial. Pediatr Crit Care Med 2013; 14 (07) 657-665
87 Amato MB, Meade MO, Slutsky AS. , et al. Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 2015; 372 (08) 747-755
88 de Jager P, Burgerhof JG, van Heerde M, Albers MJ, Markhorst DG, Kneyber MC. Tidal volume and mortality in mechanically ventilated children: a systematic review and meta-analysis of observational studies*. Crit Care Med 2014; 42 (12) 2461-2472
89 Randolph AG. Management of acute lung injury and acute respiratory distress syndrome in children. Crit Care Med 2009; 37 (08) 2448-2454
90 Santschi M, Jouvet P, Leclerc F. , et al; PALIVE Investigators; Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI); European Society of Pediatric and Neonatal Intensive Care (ESPNIC). Acute lung injury in children: therapeutic practice and feasibility of international clinical trials. Pediatr Crit Care Med 2010; 11 (06) 681-689
91 Young D, Lamb SE, Shah S. , et al; OSCAR Study Group. High-frequency oscillation for acute respiratory distress syndrome. N Engl J Med 2013; 368 (09) 806-813
92 Ferguson ND, Cook DJ, Guyatt GH. , et al; OSCILLATE Trial Investigators; Canadian Critical Care Trials Group. High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 2013; 368 (09) 795-805
93 Rettig JS, Smallwood CD, Walsh BK. , et al. High-frequency oscillatory ventilation in pediatric acute lung injury: a multicenter international experience. Crit Care Med 2015; 43 (12) 2660-2667
94 Zabrocki LA, Brogan TV, Statler KD, Poss WB, Rollins MD, Bratton SL. Extracorporeal membrane oxygenation for pediatric respiratory failure: Survival and predictors of mortality. Crit Care Med 2011; 39 (02) 364-370
95 Minneci PC, Kilbaugh TJ, Chandler HK, Behar BJ, Localio AR, Deans KJ. Factors associated with mortality in pediatric patients requiring extracorporeal life support for severe pneumonia. Pediatr Crit Care Med 2013; 14 (01) e26-e33
96 Gow KW, Wulkan ML, Heiss KF. , et al. Extracorporeal membrane oxygenation for support of children after hematopoietic stem cell transplantation: the extracorporeal life support organization experience. J Pediatr Surg 2006; 41 (04) 662-667
97 Gupta M, Shanley TP, Moler FW. Extracorporeal life support for severe respiratory failure in children with immune compromised conditions. Pediatr Crit Care Med 2008; 9 (04) 380-385
98 Brogan TV, Zabrocki L, Thiagarajan RR, Rycus PT, Bratton SL. Prolonged extracorporeal membrane oxygenation for children with respiratory failure. Pediatr Crit Care Med 2012; 13 (04) e249-e254
99 MacLaren G, Butt W, Best D, Donath S. Central extracorporeal membrane oxygenation for refractory pediatric septic shock. Pediatr Crit Care Med 2011; 12 (02) 133-136
100 Combes A, Hajage D, Capellier G. , et al; EOLIA Trial Group, REVA, and ECMONet. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018; 378 (21) 1965-1975
101 Freeman CL, Bennett TD, Casper TC. , et al. Pediatric and neonatal extracorporeal membrane oxygenation: does center volume impact mortality?*. Crit Care Med 2014; 42 (03) 512-519
102 Annane D, Sébille V, Charpentier C. , et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288 (07) 862-871
103 Sprung CL, Annane D, Keh D. , et al; CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358 (02) 111-124
104 Zimmerman JJ, Williams MD. Adjunctive corticosteroid therapy in pediatric severe sepsis: observations from the RESOLVE study. Pediatr Crit Care Med 2011; 12 (01) 2-8
105 Wong HR, Cvijanovich NZ, Anas N. , et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med 2015; 191 (03) 309-315
106 Markovitz BP, Goodman DM, Watson RS, Bertoch D, Zimmerman J. A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: what is the role of steroids?. Pediatr Crit Care Med 2005; 6 (03) 270-274
107 Atkinson SJ, Cvijanovich NZ, Thomas NJ. , et al. Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis. PLoS One 2014; 9 (11) e112702
108 Menon K, McNally JD, Choong K. , et al; Canadian Critical Care Trials Group STRIPES Investigators. A cohort study of pediatric shock: frequency of corticosteriod use and association with clinical outcomes. Shock 2015; 44 (05) 402-409
109 Yehya N, Servaes S, Thomas NJ, Nadkarni VM, Srinivasan V. Corticosteroid exposure in pediatric acute respiratory distress syndrome. Intensive Care Med 2015; 41 (09) 1658-1666
110 Drago BB, Kimura D, Rovnaghi CR. , et al. Double-blind, placebo-controlled pilot randomized trial of methylprednisolone infusion in pediatric acute respiratory distress syndrome. Pediatr Crit Care Med 2015; 16 (03) e74-e81
111 Yehya N, Vogiatzi MG, Thomas NJ, Srinivasan V. Cortisol correlates with severity of illness and poorly reflects adrenal function in pediatric acute respiratory distress syndrome. J Pediatr 2016; 177: 212-218.e1
112 Boonen E, Vervenne H, Meersseman P. , et al. Reduced cortisol metabolism during critical illness. N Engl J Med 2013; 368 (16) 1477-1488
113 Meduri GU, Headley AS, Golden E. , et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998; 280 (02) 159-165